Thermo Fisher Scientific (TMO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 9 |
Ownership rank: | 31 |
% of all portfolios: | 0.253% |
Hold Price * : | $581.21 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
83 |
$103,537,844 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
4.78 |
|
75,000 |
43,591,000 |
≡ |
Polen Capital Management |
4.37 |
Add 60.29% |
3,258,927 |
1,894,121,000 |
≡ |
AKO Capital |
3.79 |
Add 180.71% |
460,183 |
267,463,000 |
≡ |
William Von Mueffling - Cantillon Capital Management |
3.16 |
Reduce 1.96% |
864,714 |
502,581,000 |
≡ |
Chris Hohn - TCI Fund Management |
2.22 |
Reduce 51.77% |
1,517,639 |
882,067,000 |
≡ |
David Katz - Matrix Asset Advisors |
1.46 |
Reduce 4.35% |
21,011 |
12,212,000 |
≡ |
Viking Global Investors |
0.28 |
Reduce 76.14% |
128,489 |
74,679,000 |
≡ |
Thomas Gayner - Markel Group |
0.14 |
Add 26.02% |
24,700 |
14,356,000 |
≡ |
Lee Ainslie - Maverick Capital |
0.01 |
Reduce 50.76% |
749 |
435,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
06 Oct 2023 |
BOXER MICHAEL A |
SVP and General Counsel |
26 Jun 2023 |
4 |
526.15 |
2,105 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock